Positive effects of PARP-1 inhibition in KRAS-mutated intrahepatic cholangiocarcinoma is mediated by CHK1 kinase
Darko Castven,Friederike Keggenhoff, Stojan Stojkovic,Diana Becker, Jovana Castven,Carolin Zimpel,Beate Straub,Harald Langer, Patrizia Hahnel,Thomas Kindler, J?rg Fahrer,Colm O. Rourke,Lichun Ma,Xin W. Wang,Timo Gaiser,Matthias Matter,Christian Sina,Stefanie Derer,Stephanie Roessler,Bernd Kaina,Jesper Andersen,Peter Galle,Jens Marquardt JOURNAL OF HEPATOLOGY（2023）
关键词
intrahepatic cholangiocarcinoma,kinase,kras-mutated
AI 理解论文
溯源树
样例
